Prafulla Bhad - Pharmaceutical Company - Clinical Sciences Expert

Prafulla Bhad

Pharmaceutical Company

Clinical Sciences Expert

Cambridge, MA | United States

Main Specialties: Advanced Heart Failure & Transplant Cardiology, Biology, Clinical Cardiac Electrophysiology, Dermatology, Endocrinology Diabetes & Metabolism, Gastroenterology, Hematology, Hematology & Oncology, Hepatology, Infectious Disease, Internal Medicine, Interventional Cardiology, Medical Genetics, Neurology, Otolaryngology, Pediatric Otolaryngology, Pharmacology, Sleep Medicine, Vascular Surgery

Prafulla Bhad - Pharmaceutical Company - Clinical Sciences Expert

Prafulla Bhad

Publications

3Publications

64Reads

-Profile Views

Relative bioavailability of diclofenac potassium from softgel capsule versus powder for oral solution and immediate-release tablet formulation.

Clin Pharmacol Drug Dev 2016 Jan 5;5(1):76-82. Epub 2015 Oct 5.

Novartis Institutes for Biomedical Research, East Hanover, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.215DOI Listing
January 2016
37 Reads

Evaluation of two novel tablet formulations of artemether-lumefantrine (Coartem) for bioequivalence in a randomized, open-label, two-period study.

Malar J 2013 Sep 8;12:312. Epub 2013 Sep 8.

Novartis Institutes for BioMedical Research, Postfach, CH-4002, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1475-2875-12-312DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847113PMC
September 2013
22 Reads
3.109 Impact Factor

Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.

J Clin Pharmacol 2011 Jun 17;51(6):933-42. Epub 2010 Sep 17.

Translational Medicine-Scientific Operations, Novartis Healthcare Pvt Ltd, Hitech City, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270010376963DOI Listing
June 2011
5 Reads